Dec 08, 2016 12:05 pm UTC| Business
BEDMINSTER, N.J., Dec. 08, 2016 -- Matinas BioPharma Holdings, Inc. (OTCQB:MTNB), a clinical-stage biopharmaceutical company focused on identifying and developing safe and effective broad spectrum therapeutics for the...
Dec 08, 2016 12:00 pm UTC| Business
Sub-Group Analysis of the Phase 2 AtEase Clinical Study Confirms TNX-102 SL’s Potential Efficacy in Combat-Related PTSD Patients Who are the Most Difficult to Treat New Results Presented in Poster Session at the American...
Dec 08, 2016 12:00 pm UTC| Business
Data presentation at CTAD 2016 NEW YORK, Dec. 08, 2016 -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq:AVXL) today announced a positive 57-week update from its Phase 2a study in mild-to-moderate...
Dec 08, 2016 12:00 pm UTC| Business
ATB200/AT2221 Safety Data Show No Infusion-AssociatedReactions Following 100+ Infusions Clinical Pharmacokinetic (PK) Profile as Predicted Based on Previously Reported Preclinical Data Biomarkers of Muscle...
Dec 08, 2016 12:00 pm UTC| Business
Speakers include world-renowned physicians Meeting to begin at 8:00 am ET; webcast will be available DEVON, Pa., Dec. 08, 2016 -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical...
NABUFIT Debuts Neymar Jr. Videos for its Physical Fitness App and Launches Premium Version
Dec 08, 2016 12:00 pm UTC| Business
NEW YORK, Dec. 08, 2016 -- NABUFIT Global Inc. (OTCQB:NBFT), developer of a groundbreaking new training portal that enhancesindividual workouts by providing expert advice from professional trainers,health experts and...
Dec 08, 2016 12:00 pm UTC| Business
DUBLIN, Ireland, Dec. 08, 2016 -- Horizon Pharma plc (NASDAQ:HZNP), a biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and commercializing differentiated and...